(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






1748 Result: Health

The U.S. National Strategy to Counter Antisemitism: Key Actions by Pillar

June 03rd, 2023

JUNE 02, 2023 -  The Biden-Harris Administration released the U.S. National Strategy to Counter Antisemitism on May 25, 2023. The strategy outlines a whole-of-society approach to tackle the scourge of antisemitism in America.. Read more

Bipartisan Budget Agreement: President Biden Hails Historic Achievement for America's Economy and Future

June 02nd, 2023

In a historic moment for the United States, President Joe Biden praised the bipartisan effort displayed by Senators in passing the Bipartisan Budget Agreement. The President emphasized the significance of this achievement, highlighting that it not on. Read more

President Biden Applauds House Passage of Bipartisan Budget Agreement, Calls for Swift Senate Approval

June 01st, 2023

In a statement released yesterday, President Joe Biden expressed his appreciation for the House of Representatives' passage of the Bipartisan Budget Agreement, emphasizing its significance in averting a potential default and preserving the nation. Read more

FDA Conducts Retailer Inspection Blitz, Cracks Down on Illegal Sales of Popular Disposable E-cigarettes

May 31st, 2023

Washington D.C. / CRWE PRESS RELEASE / May 31, 2023 -  Today, the U.S. Food and Drug Administration issued warning letters to 30 retailers, including one distributor, for illegally selling unauthorized tobacco products. The unauth. Read more

Assessing Upgrades and Initiations: Potential Upside for Boston Beer, Cooper Companies, Constellation Brands, and Equitrans Midstream

May 30th, 2023

Boston Beer Company, Inc. (NYSE: SAM), a leading brewery and beverage company, received an upgrade from ROTH MKM, shifting from Neutral to Buy, along with a raised price target from $274 to $386.  On Tuesday, $SAM closed at $334.93, demonstra. Read more

Biotech Updates: Iovance, Vertex Pharma, Universal Health Services, Viridian Therapeutics - Potential Upsides on Analyst Views

May 30th, 2023

Several companies have received upgrades and initiations by reputable brokerage firms, investment firms, and analysts. These actions have generated interest in the market and provided price targets for each company, indicating potential upside. It. Read more

Abbott Laboratories (ABT), Millicom International Cellular (TIGO), Rain Oncology (RAIN), and NeoGames (NGMS) Face Rating Downgrades

May 30th, 2023

Several companies have experienced downgrades in their ratings today: Abbott Laboratories (NYSE: ABT), a well-known healthcare company, has been downgraded from Overweight to Equal-Weight by Morgan Stanley.   Currently, $ABT is tradin. Read more

Financial Standing: Upcoming Earnings Reports - Zumiez, Lifecore Biomedical, Tilly's, BARK, Duluth Holdings, Conn's

May 28th, 2023

Several companies are preparing to disclose their financial results on Thursday, June 1, providing valuable insights into their performance and financial standing.  Zumiez Inc. (Nasdaq: ZUMZ) is scheduled to report its fiscal 2023 first quart. Read more

Exploring Analyst Views: Upside Potential for UnitedHealth, Strategic Education, UWM Holdings, CVS Health, Mirion Technologies, Integer

May 28th, 2023

Recent developments in the stock market have brought attention to several companies, with analysts and brokerage firms providing their views on potential price targets. These targets can give investors an idea of the potential upside of a stock based. Read more

Tech, Healthcare, and Retail: Earnings Expectations for MongoDB, Cooper Companies, Zscaler, Samsara, and Five Below

May 28th, 2023

On Thursday, June 1, several companies are expected to report their financial results.   MongoDB, Inc. (Nasdaq: MDB) will announce its first quarter fiscal year 2024 financial results after the U.S. financial markets close. Analysts are . Read more

The Week On The Horizon: HP, U-Haul, Elbit Systems, Skyline Champion, JOYY - Key Insights and Expectations

May 27th, 2023

On Tuesday, May 30, several companies will be reporting their financial results.  HP Inc. (NYSE: HPQ) is set to release its second-quarter fiscal 2023 results after the market closes. Analysts expect an EPS of $0.76 on revenue of $13.09 billi. Read more

Analysts Bullish on Guardant Health, New Relic, OPAL Fuels; Diana Shipping Beats Estimates

May 26th, 2023

Diana Shipping Inc. (NYSE: DSX) has released its financial results for the first quarter of 2023, reporting earnings per share (EPS) of $0.22, surpassing the consensus estimate of $0.14. In light of its performance, the company has declared a dividen. Read more

Financial Performance and Clinical Updates: 23andMe, RH, and Aravive - Latest Reports and Future Prospects

May 26th, 2023

In the world of financial markets and healthcare, several companies have recently reported their financial performance and provided updates on their ongoing trials and future prospects. Genetic testing company 23andMe Holding Co. (Nasdaq: ME) disc. Read more

FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults

May 25th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / May 25, 2023  -  Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mil. Read more

Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.

May 24th, 2023

Washington D.C. / CRWE PRESS RELEASE / May 24, 2023 -  In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal. Read more

Load More Content